SUTRO BIOPHARMA, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $341.4M
Liabilities Breakdown FY2021
Total Liabilities: $88.8M
Asset Breakdown
Total Assets: $341.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $30.4M | 8.9% |
| Accounts Receivable | $12.5M | 3.6% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $22.6M | 6.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $276.0M | 80.8% |
Liabilities Breakdown
Total Liabilities: $88.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.0M | 6.8% |
| Long-Term Debt | $15.7M | 17.7% |
| Other Liabilities | $67.1M | 75.5% |